{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:43:28Z","timestamp":1792226608764,"version":"4.4.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,3,21]]},"DOI":"10.1097\/01.aids.0000216375.99560.a2","type":"journal-article","created":{"date-parts":[[2006,3,2]],"date-time":"2006-03-02T04:01:37Z","timestamp":1141272097000},"page":"741-749","source":"Crossref","is-referenced-by-count":183,"title":["Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion"],"prefix":"10.1097","volume":"20","member":"276","reference":[{"key":"R1-14-20210130","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(03)14570-9","article-title":"Determinants of survival following HIV-1 seroconversion after the introduction of HAART","volume":"362","author":"Porter","year":"2003","journal-title":"Lancet"},{"key":"R2-14-20210130","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"R3-14-20210130","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1086\/320164","article-title":"Changing spectrum of mortality due to human immunodeficiency virus: analysis of 260 deaths during 1995\u20131999","volume":"32","author":"Valdez","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R4-14-20210130","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1097\/00002030-200208160-00012","article-title":"Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study","volume":"16","author":"Mocroft","year":"2002","journal-title":"AIDS"},{"key":"R5-14-20210130","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00002030-200305230-00010","article-title":"Cardiovascular disease risk factors in HIV patients\u2013association with antiretroviral therapy. Results from the DAD study","volume":"17","author":"Friis-Moller","year":"2003","journal-title":"AIDS"},{"key":"R6-14-20210130","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-2141.1994.tb08312.x","article-title":"The progression of HCV-associated liver disease in a cohort of haemophilic patients","volume":"87","author":"Telfer","year":"1994","journal-title":"Br J Haematol"},{"key":"R7-14-20210130","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.aids.0000163936.99401.fe","article-title":"Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort","volume":"19","author":"Konopnicki","year":"2005","journal-title":"AIDS"},{"key":"R8-14-20210130","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(02)11913-1","article-title":"HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)","volume":"360","author":"Thio","year":"2002","journal-title":"Lancet"},{"key":"R9-14-20210130","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1097\/00002030-200008180-00019","article-title":"Pre-AIDS mortality and its association with HIV disease progression in haemophilic men, injecting drug users and homosexual men","volume":"14","author":"Prins","year":"2000","journal-title":"AIDS"},{"key":"R10-14-20210130","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/342047","article-title":"Factors associated with mortality in human immunodeficiency virus type 1-infected adults initiating protease inhibitor-containing therapy: role of education level and of early transaminase level elevation (APROCO-ANRS EP11 study). The Antiproteases Cohorte Agence Nationale de Recherches sur le SIDA EP 11 study","volume":"186","author":"Lewden","year":"2002","journal-title":"J Infect Dis"},{"key":"R11-14-20210130","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/ije\/31.5.951","article-title":"Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks","volume":"31","author":"Babiker","year":"2002","journal-title":"Int J Epidemiol"},{"key":"R12-14-20210130","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/sim.711","article-title":"Competing risks analysis of patients with osteosarcoma: a comparison of four different approaches","volume":"20","author":"Tai","year":"2001","journal-title":"Stat Med"},{"key":"R13-14-20210130","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"446","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"R14-14-20210130","first-page":"91","article-title":"The relationships between the HIV test interval, demographic factors and HIV disease progression.","volume":"127","year":"2001","journal-title":"Epidemiol Infect"},{"key":"R15-14-20210130","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0140-6736(03)13802-0","article-title":"Decline in the AIDS and death rates in the EuroSIDA study: an observational study","volume":"362","author":"Mocroft","year":"2003","journal-title":"Lancet"},{"key":"R16-14-20210130","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/00002030-200104130-00009","article-title":"Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study","volume":"15","author":"Yamashita","year":"2001","journal-title":"AIDS"},{"key":"R17-14-20210130","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/01.ede.0000135171.07103.f0","article-title":"Declining AIDS mortality in Amsterdam: contributions of declining HIV incidence and effective therapy","volume":"15","author":"Smit","year":"2004","journal-title":"Epidemiology"},{"key":"R18-14-20210130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00126334-199905010-00008","article-title":"Declining HIV\/AIDS mortality in New York City","volume":"21","author":"Chiasson","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R19-14-20210130","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/S0140-6736(05)62505-6","article-title":"Decline in deaths from AIDS due to new antiretrovirals","volume":"349","author":"Hogg","year":"1997","journal-title":"Lancet"},{"key":"R20-14-20210130","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1097\/00002030-200409030-00013","article-title":"All cause mortality in the Swiss HIV Cohort Study from 1990 to 2001 in comparison with the Swiss population","volume":"18","author":"Keiser","year":"2004","journal-title":"AIDS"},{"key":"R21-14-20210130","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1001\/jama.280.17.1497","article-title":"Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators","volume":"280","author":"Detels","year":"1998","journal-title":"JAMA"},{"key":"R23-14-20210130","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/00126334-200204010-00009","article-title":"Trends in diseases reported on U.S. death certificates that mentioned HIV infection, 1987\u20131999","volume":"29","author":"Selik","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R24-14-20210130","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00002030-200003310-00011","article-title":"Cancer risk among men with, or at risk of, HIV infection in southern Europe","volume":"14","author":"Serraino","year":"2000","journal-title":"AIDS"},{"key":"R25-14-20210130","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1086\/318501","article-title":"Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection","volume":"32","author":"Bica","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R26-14-20210130","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/S0140-6736(03)14844-1","article-title":"Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection","volume":"362","author":"Qurishi","year":"2003","journal-title":"Lancet"},{"key":"R27-14-20210130","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(04)16930-4","article-title":"HIV\/HCV coinfection, HAART, and liver-related mortality","volume":"364","author":"Sabin","year":"2004","journal-title":"Lancet"},{"key":"R28-14-20210130","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/jnci\/92.22.1823","article-title":"Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.","volume":"92","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R29-14-20210130","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/jnci\/dji072","article-title":"Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.[see comment]","volume":"97","author":"Clifford","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R30-14-20210130","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/00002030-200205240-00009","article-title":"Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis","volume":"16","author":"Grulich","year":"2002","journal-title":"AIDS"},{"key":"R31-14-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1007506617734","article-title":"Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users","volume":"15","author":"Soriano","year":"1999","journal-title":"Eur J Epidemiol"},{"key":"R32-14-20210130","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1097\/00002030-200411190-00018","article-title":"Causes of death in HIV infection: the key determinant to define the clinical response to anti-HIV therapy","volume":"18","author":"Mocroft","year":"2004","journal-title":"AIDS"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006534-200603000-00075","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:10:32Z","timestamp":1785856232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-200603210-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,21]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.aids.0000216375.99560.a2","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3,21]]}}}